Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06867484 · ClinicalTrials.gov registry record · NA
Breast Re-irradiation After Second Ipsilateral Lumpectomy
A NA study of Breast Cancer and Cancer, sponsored by Youssef Zeidan.
- Recruiting
- Registry status
- NA
- Development phase
- 114
- Enrollment target
- 2
- Study locations
NCT06867484: Recruiting NA study of Breast Cancer and Cancer, sponsored by Youssef Zeidan.
NCT06867484 is a NA study of Breast Cancer and Cancer that is actively recruiting participants, run by Youssef Zeidan. The registered enrollment target is 114 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06867484, a NA study of Breast Cancer and Cancer, is actively recruiting participants, sponsored by Youssef Zeidan.
- RECRUITING
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research study is to test the safety and possible harms of treating breast cancer with reirradiation, after breast surgery. The researchers want to find out what effects (good and bad) reirradiation has on people who have already received radiation before surgery.
Primary Outcome
Adverse events will be collected using Common Terminology Criteria for Adverse Events version 5 (CTCAE v5) starting from the first radiation treatment. Grade 1 AEs are considered mild, grade 2 AEs are considered moderate, grade 3 AEs are considered severe, grade 4 AEs are considered life-threatening, and grade 5 AEs are considered fatal. The percentage of participants experiencing grade 3 or higher treatment-related AEs will be calculated.
Conditions Studied
Interventions
- RADIATION Intensity modulated radiation therapy (IMRT)
Study Locations (2)
Florida
- Lynn Cancer Institute at Baptist Health, Inc. - Boca Raton
- Miami Cancer Institute at Baptist Health, Inc. - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2025-10-27 |
| Est. Completion | 2033-05 |
| Phase | NA |
What NCT06867484 shows while recruiting
NCT06867484 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower).
The record links to 6 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Intensity modulated radiation therapy (IMRT) is the first listed.
NCT06867484 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06867484 about?
NCT06867484 is a clinical study titled "Breast Re-irradiation After Second Ipsilateral Lumpectomy". The purpose of this research study is to test the safety and possible harms of treating breast cancer with reirradiation, after breast surgery. The researchers want to find out what effects (good and bad) reirradiation has on people who have already received radiation before surgery.
What is the current status of trial NCT06867484?
This trial is currently recruiting. It is a NA study. The enrollment target is 114 participants. The study started on 2025-10-27. Estimated completion is 2033-05.
What conditions does trial NCT06867484 study?
This clinical trial studies the following conditions: Breast Cancer, Cancer, HER2-Negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, Cancer of the Breast.
What interventions are being tested in trial NCT06867484?
The interventions under investigation include: Intensity modulated radiation therapy (IMRT) (RADIATION).
Who is sponsoring clinical trial NCT06867484?
This trial is sponsored by Youssef Zeidan, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06867484 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06867484's enrollment target sits among peer trials
114 529th of 1224 higher than 695 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI